TY - JOUR
T1 - Pf4 bacteriophage produced by Pseudomonas aeruginosa inhibits Aspergillus fumigatus metabolism via iron sequestration
AU - Penner, Jack C.
AU - Ferreira, Jose A.G.
AU - Secor, Patrick R.
AU - Sweere, Johanna M.
AU - Birukova, Maria K.
AU - Joubert, Lydia Marie
AU - Haagensen, Janus A.J.
AU - Garcia, Omar
AU - Malkovskiy, Andrey V.
AU - Kaber, Gernot
AU - Nazik, Hasan
AU - Manasherob, Robert
AU - Spormann, Alfred M.
AU - Clemons, Karl V.
AU - Stevens, David A.
AU - Bollyky, Paul L.
N1 - Publisher Copyright:
© 2016 The Authors.
PY - 2016/9
Y1 - 2016/9
N2 - Pseudomonas aeruginosa (Pa) and Aspergillus fumigatus (Af) are major human pathogens known to interact in a variety of disease settings, including airway infections in cystic fibrosis. We recently reported that clinical CF isolates of Pa inhibit the formation and growth of Af biofilms. Here, we report that the bacteriophage Pf4, produced by Pa, can inhibit the metabolic activity of Af biofilms. This phage-mediated inhibition was dose dependent, ablated by phage denaturation, and was more pronounced against preformed Af biofilm rather than biofilm formation. In contrast, planktonic conidial growth was unaffected. Two other phages, Pf1 and fd, did not inhibit Af, nor did supernatant from a Pa strain incapable of producing Pf4. Pf4, but not Pf1, attaches to Af hyphae in an avid and prolonged manner, suggesting that Pf4-mediated inhibition of Af may occur at the biofilm surface. We show that Pf4 binds iron, thus denying Af a crucial resource. Consistent with this, the inhibition of Af metabolism by Pf4 could be overcome with supplemental ferric iron, with preformed biofilm more resistant to reversal. To our knowledge, this is the first report of a bacterium producing a phage that inhibits the growth of a fungus and the first description of a phage behaving as an iron chelator in a biological system.
AB - Pseudomonas aeruginosa (Pa) and Aspergillus fumigatus (Af) are major human pathogens known to interact in a variety of disease settings, including airway infections in cystic fibrosis. We recently reported that clinical CF isolates of Pa inhibit the formation and growth of Af biofilms. Here, we report that the bacteriophage Pf4, produced by Pa, can inhibit the metabolic activity of Af biofilms. This phage-mediated inhibition was dose dependent, ablated by phage denaturation, and was more pronounced against preformed Af biofilm rather than biofilm formation. In contrast, planktonic conidial growth was unaffected. Two other phages, Pf1 and fd, did not inhibit Af, nor did supernatant from a Pa strain incapable of producing Pf4. Pf4, but not Pf1, attaches to Af hyphae in an avid and prolonged manner, suggesting that Pf4-mediated inhibition of Af may occur at the biofilm surface. We show that Pf4 binds iron, thus denying Af a crucial resource. Consistent with this, the inhibition of Af metabolism by Pf4 could be overcome with supplemental ferric iron, with preformed biofilm more resistant to reversal. To our knowledge, this is the first report of a bacterium producing a phage that inhibits the growth of a fungus and the first description of a phage behaving as an iron chelator in a biological system.
UR - http://www.scopus.com/inward/record.url?scp=84992386213&partnerID=8YFLogxK
U2 - 10.1099/mic.0.000344
DO - 10.1099/mic.0.000344
M3 - Article
C2 - 27473221
AN - SCOPUS:84992386213
SN - 1350-0872
VL - 162
SP - 1583
EP - 1594
JO - Microbiology
JF - Microbiology
IS - 9
ER -